Company
Overview
For Investors
News
Team
Executive Board
Management Team
Scientific Advisory Board
Pertussis
Whooping Cough
B. pertussis
Bacteria
Treatment vs Prevention
Subclinical Colonization + Transmission
Adult/adolescent Boosters
Our Science
BPZE1 Vaccine
Why a Live Vaccine?
Preventing Colonization + Transmission
Preclinical Safety
BPZE1 Publications
Disease Science
- Alzheimer’s Disease
- Allergic Disease
- Autoimmune Disease
Clinical
Opportunity
Market
Pipeline
Intellectual Property
B-Tech
Targeting Disease
with
B-Tech
B-Tech
Vector Platform
Vaccine Candidates
B. Pertussis
Disease Research
BioLyo Tech
Contact
With 200,000 deaths and 16 million global cases of pertussis each year, the importance of our mission is clear.
Infant with Pertussis
Child with Pertussis
Adult with Pertussis
Copyright 2013-2023 ILiAD Biotechnologies